Patents by Inventor Oleg V. KOVALENKO

Oleg V. KOVALENKO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD1a ANTIBODIES AND USES THEREOF
    Publication number: 20240076382
    Abstract: Antibodies, and antigen-binding fragments thereof, that specifically bind to Cluster of Differentiation 1a (CD1a) are provided. Embodiments include uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Application
    Filed: July 19, 2023
    Publication date: March 7, 2024
    Applicants: Pfizer Inc., Children's Medical Center Corporation
    Inventors: Florian WINAU, Oleg V. KOVALENKO, Chew Shun CHANG, Di WU, Nicholas Andrew MARZE, Shian-Huey CHIANG
  • CD1a antibodies and uses thereof
    Patent number: 11746154
    Abstract: Antibodies, and antigen-binding fragments thereof, that specifically bind to Cluster of Differentiation 1a (CD1a) are provided. Embodiments include uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Grant
    Filed: October 7, 2021
    Date of Patent: September 5, 2023
    Assignees: Pfizer Inc., Children's Medical Center Corporation
    Inventors: Florian Winau, Oleg V. Kovalenko, Chew Shun Chang, Di Wu, Nicholas Andrew Marze, Shian-Huey Chiang
  • CD1a ANTIBODIES AND USES THEREOF
    Publication number: 20220112291
    Abstract: Antibodies, and antigen-binding fragments thereof, that specifically bind to Cluster of Differentiation 1a (CD1a) are provided. Embodiments include uses, and associated methods of using the antibodies, and antigen-binding fragments thereof.
    Type: Application
    Filed: October 7, 2021
    Publication date: April 14, 2022
    Applicants: Pfizer Inc., Children's Medical Center Corporation
    Inventors: Florian WINAU, Oleg V. KOVALENKO, Chew Shun CHANG, Di WU, Nicholas Andrew MARZE, Shian-Huey CHIANG